Oncology Information Systems
Oncology Information Systems Market by Solutions (Advanced Visualization & Image Analysis Solutions, Brachytherapy Treatment Planning Systems, Chemotherapy Information System), Service (Consulting/Optimization Services, Implementation Services, Post-Sale & Maintenance Services), Application, End User - Global Forecast 2024-2030
360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the oncology information systems market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[195 Pages Report] The Oncology Information Systems Market size was estimated at USD 8.85 billion in 2023 and expected to reach USD 9.55 billion in 2024, at a CAGR 8.50% to reach USD 15.67 billion by 2030.

Oncology Information Systems (OIS) are integrated, specialized platforms designed to manage the complex data and workflow processes associated with cancer treatment. Oncology Information systems provide a comprehensive suite of tools that assist clinicians, oncologists, and healthcare providers in efficiently planning, managing, and monitoring the entire cancer care continuum from diagnosis to survivorship. The growing prevalence of cancer, focus on integrated healthcare systems, and rising demand for personalized medicine expansion of healthcare infrastructure increase market adoption. However, concerns regarding data security and privacy in storing and managing patient records may impede market growth. Nevertheless, enhanced cloud-based solutions for remote access and real-time collaboration among oncology specialists and the development of mobile applications for patient engagement and real-time monitoring are expected to create potential opportunities for market growth.

Regional Insights

In the Americas, the demand for Oncology Information Systems (OIS) is driven by the increasing incidence of cancer, technological advancements, and the implementation of healthcare reforms supporting oncology research. Advanced healthcare infrastructure and high per capita healthcare expenditure contribute to a favorable market environment. In Canada, government initiatives and funding for cancer research support the adoption of OIS. European Union (EU) countries exhibit a high demand for OIS due to their well-established healthcare systems and active participation in cancer research. The General Data Protection Regulation (GDPR) has also influenced the development and implementation of OIS to ensure patient data security and privacy. Significant investments in personalized medicine and integrated care models are prevalent in the region. The OIS market in the Middle East and Africa is emerging, with the Middle East showing faster adoption due to increasing healthcare expenditure and infrastructure development. In Africa, the market growth is slower due to resource constraints; however, it presents a long-term opportunity with gradual economic and healthcare improvements. In the Asia-Pacific region, especially in China and Japan, government initiatives for cancer control, increasing healthcare expenditure, and the aging population are significant factors driving the OIS market. India, on the other hand, presents a rapidly growing market due to the rising incidence of cancer and ongoing improvements in healthcare infrastructure.

Oncology Information Systems Market
To learn more about this report, request a free PDF copy
Market Dynamics

The market dynamics represent an ever-changing landscape of the Oncology Information Systems Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Increasing incidence and prevalence of cancer worldwide
    • Growing adoption of EHRs and other oncology healthcare IT solutions to improve care quality
    • Favorable government mandates and support for oncology information systems
  • Market Restraints
    • Dearth of skilled IT professionals in healthcare industry
  • Market Opportunities
    • Integration of advanced technologies with Oncology Information Systems
    • Increasing strategic alliances and investments
  • Market Challenges
    • Concerns regarding data privacy and security
Market Segmentation Analysis
  • Solutions: Burgeoning usage of chemotherapy information systems to reduce medication errors

    Advanced Visualization & Image Analysis Solutions provide high-resolution images and tools for detailed anatomical assessments, crucial in identifying and characterizing tumors used in complex cases requiring precise imaging, such as brain or pancreatic cancer. Brachytherapy Treatment Planning Systems is software specializing in the planning of internal radiotherapy, allowing precision in the delivery of treatment to cancerous tissues while sparing surrounding healthy tissue, which is essential for cancers treatable with brachytherapy, such as cervical or prostate cancer. Clinical Decision Support Systems assist physicians in making decisions based on analytical data, such as patient history and scientific guidelines, and are used for all oncology practices to ensure evidence-based treatment. Clinical Integration solutions ensure that various oncology-related software systems can communicate and exchange data efficiently, which is essential for healthcare providers using multiple systems. Laboratory Information Systems is a digital platform that manages medical laboratory operations, crucial for cancer centers that conduct frequent lab tests. Oncology Electronic Medical Record (EHR) systems are designed to address the complex needs of oncology treatments and patient management, and they are integral for all oncology practices for comprehensive patient record-keeping. Picture Archiving & Communication System (PACS) & Vendor Neutral Archive (VNA) systems store and allow secure sharing of medical images across healthcare systems and are vital for radiology departments and multi-site practices. Population Health Management is a tool designed to analyze and manage patient data across a population to improve healthcare outcomes on a large scale. Radiation Dose Management Solutions aimed at tracking and minimizing radiation exposure to patients during diagnostic and therapeutic procedures for practices offering radiation therapy. Radiology Information Systems for managing workflow and patient data in the radiology department of a hospital or a clinic. Radiotherapy Treatment Planning Systems are advanced software that provides radiation oncologists with tools to plan and simulate radiotherapy treatment, essential for centers providing radiotherapy. Treatment Management Systems & Medical Image Analysis Systems encompass a range of systems used to manage the entire treatment process, from diagnosis through post-treatment follow-up, and include sophisticated image analysis for medical diagnosis. Treatment Planning Systems are used for planning complex cancer treatments, integrating multiple treatment modalities and schedules into a coherent plan, and are necessary for facilities that offer multi-modal cancer treatments.

  • Application: Evolving usage of oncology information systems for surgical oncology

    Medical Oncology incorporates the use of chemotherapy, hormonal therapy, biological therapy, and targeted therapy to treat cancer. OIS in medical oncology is centered around the patient management system, providing a comprehensive solution for managing the patient's medical history, medication orders, treatment scheduling, and tracking of patient outcomes. It often includes clinical decision support systems to help oncologists choose the proper chemotherapy regimens based on evidence-based protocols. Radiation Oncology focuses on the administration of radiation therapy to eliminate cancer cells. OIS for radiation oncology typically features treatment planning systems, dose management, image-guided radiation therapy (IGRT) systems, and machine parameters controlling radiation delivery. The system ensures precise targeting, minimizing damage to surrounding healthy tissues. Surgical Oncology involves the surgical excision of cancerous tumors and is often complemented by other treatments. Within OIS, surgical oncology applications focus on preoperative planning, operative navigation, postoperative care, and the documentation of surgical interventions. They may integrate with picture archiving and communication systems (PACS) and electronic health records (EHR) for improved clinical workflows. Surgical oncology requires detailed planning and coordination of care. OIS aids in scheduling surgeries, tracking patient recovery, and managing follow-up care, which is highly beneficial for a patient's continuum of care.

Market Disruption Analysis

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Oncology Information Systems Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Oncology Information Systems Market.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Oncology Information Systems Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

Value Chain & Critical Path Analysis

The value chain of the Oncology Information Systems Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

Pricing Analysis

The pricing analysis comprehensively evaluates how a product or service is priced within the Oncology Information Systems Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Oncology Information Systems Market.

Technology Analysis

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Oncology Information Systems Market.

Patent Analysis

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Oncology Information Systems Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

Trade Analysis

The trade analysis of the Oncology Information Systems Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

Regulatory Framework Analysis

The regulatory framework analysis for the Oncology Information Systems Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

As a leading healthcare technology company, we faced significant challenges in integrating advanced technologies with our Oncology Information Systems. The 360iResearch Oncology Information Systems Market Research Report provided valuable insights and actionable strategies that transformed our approach. From data management to workflow optimization, the report's findings have been instrumental in enhancing our operational efficiency. We highly recommend this report for any organization seeking to innovate and improve their oncology information systems.
CureMD.com, Inc.
FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Oncology Information Systems Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Oncology Information Systems Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Apollo Cancer Centres launches India's 1st AI-Precision Oncology Centre

    Apollo Cancer Centres established India's first Artificial Intelligence (AI) Precision Oncology Centre, pioneering a new era of cancer care. This state-of-the-art facility is equipped with advanced AI-enabled systems designed to enhance the accuracy and efficacy of cancer treatment. By leveraging big data analytics and machine learning algorithms, the center aims to personalize oncology therapies, offering hope for improved patient outcomes. [Published On: 2024-01-23]

  • GBIN Launches eNautilus Project to Add New Oracle Health EHR Capabilities to Better Support Patient Care

    GBIN unveiled its eNautilus initiative, a strategic project to integrate advanced Oracle Health EHR functionalities. This groundbreaking effort is set to revolutionize how natural disaster detection is managed through the innovative use of Internet of Things (IoT) technology. The overhaul aims to provide a robust system to efficiently predict and respond to natural calamities, leveraging Oracle's cutting-edge tech to enhance data collection, analysis, and dissemination. Suspicious environmental alterations that could indicate potential disasters will be identified more rapidly, allowing prompt action. [Published On: 2023-09-26]

  • Nova Scotia Health Launches First-In-Canada Technology that Brings Together Oncology Information In Real-Time

    Nova Scotia Health unveiled a pioneering oncology information system. This state-of-the-art technology is the first in Canada to be integrated to streamline patient information across multiple platforms within oncology departments. The innovative system aims to enhance cancer care delivery by consolidating treatment plans, test results, and medical images into one easily accessible digital platform. The new information system represents a significant milestone in improving oncology services, demonstrating a commitment to employing cutting-edge technology to support healthcare professionals and patients in the fight against cancer. [Published On: 2023-02-17]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Oncology Information Systems Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Before accessing the Oncology Information Systems Market Research Report by 360iResearch, EndoSoft LLC faced significant challenges in identifying potential strategic alliances and investment opportunities. The report provided not only valuable insights but also actionable strategies that directly addressed our needs. One of the most impactful findings was the identification of emerging market leaders, which allowed us to strategically align with key players for mutual growth. The thorough analysis on market trends and investment opportunities helped us make informed decisions, resulting in improved operational efficiency and increased revenue. Overall, from comprehensive data to practical advice, the report has been instrumental in positively transforming our business operations and guiding us toward strategic growth. We highly recommend 360iResearch for their well-researched and impactful reports.
EndoSoft LLC
Key Company Profiles

The report delves into recent significant developments in the Oncology Information Systems Market, highlighting leading vendors and their innovative profiles. These include CureMD.com, Inc., EndoSoft LLC, Koninklijke Philips N.V., Oracle Corporation, Altai AS, RaySearch Laboratories, McKesson Corporation, Sify Technologies, Elekta AB, International Business Machines Corporation, ViewRay Inc., MICA Information Systems, Inc.​​, F. Hoffmann-La Roche Ltd, Advanced Data Systems Corporation, Karkinos Healthcare, Advanced Data Systems, UnitedHealth Group Inc., GE HealthCare Technologies Inc., Epic Systems Corporation, DOSIsoft SA, Siemens Healthineers AG, Allscripts Healthcare Solutions, Inc., and Accuray Incorporated.

Oncology Information Systems Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Market Segmentation & Coverage

This research report categorizes the Oncology Information Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Solutions
    • Advanced Visualization & Image Analysis Solutions
    • Brachytherapy Treatment Planning Systems
    • Chemotherapy Information System
    • Clinical Decision Support Systems
    • Clinical Integration Solutions
    • Laboratory Information Systems
    • Oncology Electronic Medical Record (EHR)
    • Patient Information Systems
    • Picture archiving & communication System (PACS) & VNA
    • Population Health Management
    • Radiation Dose Management Solutions
    • Radiology Information systems
    • Radiotherapy Treatment Planning Systems
    • Treatment Management Systems & Medical Image Analysis Systems
    • Treatment Planning Systems
  • Service
    • Consulting/Optimization Services
    • Implementation Services
    • Post-Sale & Maintenance Services
  • Application
    • Medical Oncology
    • Radiation Oncology
    • Surgical Oncology
  • End User
    • Ablation Care Centers & Cancer Care Centers
    • Government Institutions
    • Hospitals & Diagnostic Imaging Centers
    • Research Facilities

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The Oncology Information Systems Market Research Report by 360iResearch proved to be an invaluable asset for us. Faced with the growing prevalence of cancer worldwide, we struggled with staying ahead of market trends and identifying actionable strategies. Thanks to the comprehensive insights and data provided by the report, we were able to refine our approach, lead impactful initiatives, and ultimately enhance our capabilities to serve cancer patients better. The report's in-depth analysis facilitated our decision-making process, resulting in optimized operations and increased market presence. We are extremely satisfied with the positive impact it has had on our organization.
Koninklijke Philips N.V.
This research report offers invaluable insights into various crucial aspects of the Oncology Information Systems Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Oncology Information Systems Market, by Solutions
  7. Oncology Information Systems Market, by Service
  8. Oncology Information Systems Market, by Application
  9. Oncology Information Systems Market, by End User
  10. Americas Oncology Information Systems Market
  11. Asia-Pacific Oncology Information Systems Market
  12. Europe, Middle East & Africa Oncology Information Systems Market
  13. Competitive Landscape
  14. Competitive Portfolio
  15. List of Figures [Total: 24]
  16. List of Tables [Total: 402]
  17. List of Companies Mentioned [Total: 23]
Frequently Asked Questions
  1. How big is the Oncology Information Systems Market?
    Ans. The Global Oncology Information Systems Market size was estimated at USD 8.85 billion in 2023 and expected to reach USD 9.55 billion in 2024.
  2. What is the Oncology Information Systems Market growth?
    Ans. The Global Oncology Information Systems Market to grow USD 15.67 billion by 2030, at a CAGR of 8.50%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.